Skip to content

Rib Fixation for Clinically Severe Rib Fractures From Trauma

A Multicenter Prospective Randomized Trial on the Intervention of Rib Fixation for Clinically Severe Rib Fractures From Trauma

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02595593
Acronym
SOFRIB
Enrollment
236
Registered
2015-11-03
Start date
2015-04-30
Completion date
2023-12-31
Last updated
2022-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Flail Chest, Rib Fracture

Keywords

Trauma, Rib Plate, Rib Fixation

Brief summary

This is a multicenter randomized study investigating the differences in clinical outcomes of patients between two standard of care pathways for rib trauma: patients who receive rib fixation versus patients who receive modern critical care and pain control after sustaining clinically significant rib fractures from trauma.

Detailed description

This study will compare the outcomes of patients between two standard of care pathways for rib trauma: those who have their ribs plated versus those who are managed by modern critical care and pain control. A study nurse (project) coordinator will identify subjects based on inclusion and exclusion criteria, then obtain consent for each of these patients prior to randomization. Randomization will be decided by a web-based computer program, accessible to the project coordinator. Although this randomization occurs, the study itself is purely observational, as the intervention is currently standard of care. None of the subjects or study group members will be blinded since it is not possible to disguise the intervention. Patients will be evaluated and a survey will be administered at set post-intervention intervals to determine endpoints and quality of life when data analysis will also take place.

Interventions

DEVICERib Fixation System

This intervention involves a surgical procedure to affix rib plates to broken ribs

Sponsors

Darwin Ang
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Flail chest, defined as 3 or more consecutive ribs fractured in more than one place * Pain and disability of an FPS (Functional Pain Scale) rating of 3 or higher * Deformity and Defect * Non-Union * Thoracotomy for other indications * 3 or more rib fractures with rib displacement of more than 1 rib cortical diameter * Failure to wean from ventilator

Exclusion criteria

* Active bacteremia * Active shock * Severe Traumatic Brain Injury with GCS \< 8 * Age 17 years or less or age greater than 90 years old * Chronic pulmonary disease requiring home oxygenation * Acute Respiratory Distress Syndrome * Penetrating chest trauma * Chronic opioid dependence * Fractures less than 3cm from vertebral spine

Design outcomes

Primary

MeasureTime frameDescription
ICU Length of Staymeasured through study completion, up to 2 yearslength of stay in days

Secondary

MeasureTime frameDescription
Quality of Life, as determined by SF-36 surveymeasured at 1 week, 3 months, 6 months post-interventionmeasured at 3 different time points post-hospital stay
Number of participants with pneumonia as defined by the Centers for Disease Controlmeasured monthly through course of study, up to 2 yearsbased on classification as complication of rib trauma treatment
Total cost of treatmentsmeasured through study completion, up to 2 yearsmeasured based on total costs during length of hospital stay

Other

MeasureTime frameDescription
Pulmonary Functionmeasured at discharge, 3 months, and 6 months, through study completion, up to 2 yearsas measured by FVC (forced vital capacity), FEV1, and TLC by spirometry
Time to wean from ventilatormeasured through study completion, up to 2 yearsmeasured in days
Pain Control documented by the Functional Pain Scalemeasured before and after surgery and at time of discharge, through study completion, up to 2 yearsmeasured using the Functional Pain Scale
Complication Ratesmeasured at 1 week, 3 months, 6 monthsincluding, but not limited to, pneumonia, urinary tract infection, arrhythmia, sepsis, reintubation, wound infection
Tracheostomy ratesmeasured at 1 week, 3 months, 6 monthsoverall rate of tracheostomy in population
Ventilator/Ventilator Free Daysmeasured through study completion, up to 2 yearsmeasured in days on or off ventilation, based on length of stay in hospital
Narcotic usagemeasured at 1 week, 3 months, 6 monthsconverted to units of morphine
Hospital length of staymeasured through study completion, up to 2 yearsmeasured in days

Countries

United States

Contacts

Primary ContactDonna Nayduch, RN, MSN
donna.nayduch@hcahealthcare.com352-401-1022

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026